Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
AFL heads into its November 4 earnings date with analyst opinion pulling in opposite directions and its largest institutional shareholder quietly reducing its position through a pre-arranged sale plan.
The most striking development this week is the fresh analyst divergence. Mizuho cut its price target to $107 from $116 on October 7, maintaining an Underperform rating, a signal that at least one broker sees meaningful downside from the current $113.63 price. Against that, Barclays nudged its target up to $101 from $99 while holding Underweight, and UBS raised to $125 from $124 with a Neutral stance. The result is a Street that spans from $101 to $138 in price targets, with the mean at $118. The bears question whether Aflac's Japan business is losing momentum: reported EPS of $1.75 came in below the $1.80 consensus last quarter, Japan's benefit ratio ran above expectations, and US net earned premiums fell 2.1%, short of the 3% to 6% guidance range. The bulls point to a $4.8 billion portfolio repositioning adding over $50 million in annualized pre-tax net investment income, capital-efficient Japan liability ceding that could free $2.5 billion over time, and US persistency holding at 79.3%. Piper Sandler sits at the optimistic end with an Overweight and a $138 target, set in August; the cluster of Neutral-to-Underperform ratings closer to the current price tells a more cautious story.
Positioning in the lending market and options offers little drama. Short interest is barely worth noting at 2.1% of the free float, down about 1.4% across the past week and trending lower for the past month. Borrow is close to free at 0.49% cost-to-borrow, and availability is essentially unlimited at 7,190%, meaning there are vastly more shares available to lend than there are short positions to fill. That rules out any squeeze narrative. Options are similarly quiet: the put/call ratio of 0.48 is marginally below the 20-day average of 0.53, with a z-score of -0.57, well within normal range. The 52-week PCR band runs from 0.21 to 0.73, and the current reading sits in the calmer half of that range. Nothing in the lending or options data amplifies the bearish analyst case.
The more concrete supply-side development comes from Japan Post Holdings, which holds 10.1% of AFL and has been filing steady sales under a 10b5-1 plan. Over the past ten days, Japan Post has sold roughly 63,000 shares across multiple transactions at prices between $110.93 and $114.25, totalling around $7.8 million. Net of all insiders over the past 90 days, sales amount to approximately 424,600 shares worth $49 million. Because these trades are pre-arranged under a 10b5-1 plan, they carry less informational weight than discretionary sales, and Japan Post's stake remains substantial at 50.4 million shares. Still, a 10% holder in systematic sell mode provides a steady, visible supply overhang worth tracking.
On the factor side, Aflac's dividend score ranks in the 98th percentile of the universe, reflecting the stock's longstanding income appeal, though the dividend history data in the snapshot dates to 2022 and cannot be verified as current. Valuation sits at a trailing PE of 15.3 and a price-to-book of 1.84, with both multiples contracting slightly over the past 30 days. The short score of 36.8 has edged down modestly over the past two weeks, consistent with the gentle unwind in short interest. EPS momentum scores are weak at 49 for the 30-day reading and 26 for 90 days, reflecting the estimate-miss backdrop that underpins the bear case. Wikipedia page views for AFL spiked to a z-score of 2.1 against its own 90-day history in late September, a retail attention signal worth noting without reading too much into it.
Among peers, CB added 1.1% on the day while WRB dipped 0.2% and ALL was flat, leaving AFL's flat week broadly in line with the sector. The next event that matters is the November 4 earnings print, where the debate between Japan benefit ratio trajectory, US premium trends, and the pace of capital release from the liability-ceding programme will move from analyst models to reported figures.
See the live data behind this article on ORTEX.
Open AFL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.